Syngene | Zee News

Advertisement

Syngene News

22 Jun 2015

Syngene gets nod to raise foreign investment to 44%

Syngene, a subsidiary of Biocon, on Monday said it has received the Foreign Investment Promotion Board (FIPB) approval for raising foreign investment in the company to 44 percent from the earlier approved 10 percent.

Foreign direct investment

17 Jun 2015

Govt approves FDI worth Rs 4,000 cr in pharma sector

Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.

23 Apr 2015

Biocon files IPO prospectus for R&D arm Syngene

Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.

22 Apr 2015

Biocon files prospectus for Syngene IPO to raise Rs 600 cr

Biotechnology major Biocon Wednesday filed prospectus with market regulator SEBI for the initial public offer of its research arm Syngene through which aims to raise around Rs 600 crore that will be used to fund its R&D programmes.

01 Apr 2015

Biocon arm Syngene appoints Peter Bains as CEO

Biotechnology major Biocon's custom research arm Syngene has appointed Peter Bains as its Chief executive Officer (CEO).

23 Jan 2015

Biocon says to take Syngene unit public

Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings.

12 Jan 2015

Biocon completes 10% stake sale in Syngene

Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.

Loading...